The National Dexamethasone shows promise treating severe COVID-19 patients

The National Dexamethasone shows promise treating severe COVID-19 patients

Researchers in the U.K. say dexamethasone, a widely available corticosteroid, reduced COVID-19 deaths by up to one-third in severely ill hospitalized patients.

  • 2020
  • 00:03:38
  • 13-14
  • Added on: 07/03/2020
Curio.ca users can access content from outside their institution. You must find your access code and then create an account.

Metadata

Subjects
COVID-19 (Disease) [LCSH] Coronavirus infections -- Treatment [LCSH] Glucocorticoids [LCSH] Science [LCSH] Medical sciences [LCSH]
Team
Christine Birak (Journalist), Andrew Chang (Host)
Closed captioning
Available
MARC Record
View Download

Can be found in

Categories

The new version of Curio is available!

Access this page through the new version and discover a whole new experience.

Try the new version